FI823112A7 - Nalbufiini-narkoottinen analgeettikoostumus ja menetelmä kivuntunnon poistamiseksi. - Google Patents

Nalbufiini-narkoottinen analgeettikoostumus ja menetelmä kivuntunnon poistamiseksi. Download PDF

Info

Publication number
FI823112A7
FI823112A7 FI823112A FI823112A FI823112A7 FI 823112 A7 FI823112 A7 FI 823112A7 FI 823112 A FI823112 A FI 823112A FI 823112 A FI823112 A FI 823112A FI 823112 A7 FI823112 A7 FI 823112A7
Authority
FI
Finland
Prior art keywords
nalbuphine
pain sensation
narcotic analgesic
analgesic composition
eliminating pain
Prior art date
Application number
FI823112A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI823112L (fi
FI823112A0 (fi
Inventor
Michael Richard Magruder
Original Assignee
Michael Richard Magruder
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Michael Richard Magruder filed Critical Michael Richard Magruder
Publication of FI823112A0 publication Critical patent/FI823112A0/fi
Publication of FI823112L publication Critical patent/FI823112L/fi
Publication of FI823112A7 publication Critical patent/FI823112A7/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI823112A 1981-09-08 1982-09-08 Nalbufiini-narkoottinen analgeettikoostumus ja menetelmä kivuntunnon poistamiseksi. FI823112A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/300,394 US4366159A (en) 1981-09-08 1981-09-08 Nalbuphine-narcotic analgesic composition and method of producing analgesia

Publications (3)

Publication Number Publication Date
FI823112A0 FI823112A0 (fi) 1982-09-08
FI823112L FI823112L (fi) 1983-03-09
FI823112A7 true FI823112A7 (fi) 1983-03-09

Family

ID=23158917

Family Applications (1)

Application Number Title Priority Date Filing Date
FI823112A FI823112A7 (fi) 1981-09-08 1982-09-08 Nalbufiini-narkoottinen analgeettikoostumus ja menetelmä kivuntunnon poistamiseksi.

Country Status (14)

Country Link
US (1) US4366159A (OSRAM)
EP (1) EP0074105A1 (OSRAM)
JP (1) JPS5855422A (OSRAM)
AR (1) AR228984A1 (OSRAM)
AU (1) AU549070B2 (OSRAM)
CA (1) CA1200501A (OSRAM)
FI (1) FI823112A7 (OSRAM)
GR (1) GR76702B (OSRAM)
HU (1) HU190699B (OSRAM)
IL (1) IL66743A (OSRAM)
NZ (1) NZ201841A (OSRAM)
PH (1) PH18772A (OSRAM)
PT (1) PT75521A (OSRAM)
ZA (1) ZA826500B (OSRAM)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4477457A (en) * 1982-10-28 1984-10-16 E. I. Du Pont De Nemours And Company Method for inducing anorexia using nalmetrene
US4478840A (en) * 1983-10-11 1984-10-23 E. I. Du Pont De Nemours And Company Appetite suppressing compositions and methods
US4885173A (en) * 1985-05-01 1989-12-05 University Of Utah Methods and compositions for noninvasive dose-to-effect administration of drugs with cardiovascular or renal vascular activities
US4769372A (en) * 1986-06-18 1988-09-06 The Rockefeller University Method of treating patients suffering from chronic pain or chronic cough
GB8820327D0 (en) * 1988-08-26 1988-09-28 May & Baker Ltd New compositions of matter
US5236714A (en) * 1988-11-01 1993-08-17 Alza Corporation Abusable substance dosage form having reduced abuse potential
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
HU218673B (hu) * 1993-10-07 2000-10-28 Euroceltique S.A. Opioid analgetikumot tartalmazó elnyújtott hatóanyag-felszabadítású orális gyógyszerkészítmény és eljárás előállítására
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
US6348216B1 (en) * 1996-06-10 2002-02-19 Knoll Pharmaceutical Company Ibuprofen and narcotic analgesic compositions
US6361794B1 (en) 1996-06-12 2002-03-26 Basf Corporation Method of making ibuprofen and narcotic analgesic composition
WO2003004033A1 (en) 2001-07-06 2003-01-16 Penwest Pharmaceuticals Company Sustained release formulations of oxymorphone
WO2003004030A1 (en) * 2001-07-06 2003-01-16 Endo Pharmaceuticals, Inc. Oxymorphone controlled release formulations
US8329216B2 (en) 2001-07-06 2012-12-11 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
US20140271788A1 (en) 2013-03-15 2014-09-18 Monosol Rx, Llc Sublingual and buccal film compositions
PT2939696E (pt) 2001-10-18 2016-06-17 Nektar Therapeutics Conjugados poliméricos de antagonistas de opióides
EP2422773A3 (en) 2002-09-20 2012-04-18 Alpharma, Inc. Sequestering subunit and related compositions and methods
US7192966B2 (en) * 2002-11-15 2007-03-20 Branded Products For The Future Pharmaceutical composition
AU2003296954A1 (en) * 2002-12-13 2004-07-09 The Regents Of The University Of California Analgesic combination comprising nalbuphine
RS53279B (sr) * 2003-12-16 2014-08-29 Nektar Therapeutics Monodisperzne smeše pegilisanog naloksola
US20060182692A1 (en) * 2003-12-16 2006-08-17 Fishburn C S Chemically modified small molecules
ES2636657T3 (es) 2006-06-19 2017-10-06 Alpharma Pharmaceuticals Llc Composición farmacéutica
US20080318994A1 (en) 2007-06-21 2008-12-25 Endo Pharmaceuticals, Inc. Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Renal Impairment
US20080318993A1 (en) * 2007-06-21 2008-12-25 Endo Pharmaceuticals, Inc. Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Hepatic Impairment
US8623418B2 (en) 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
FR2963889B1 (fr) * 2010-08-20 2013-04-12 Debregeas Et Associes Pharma Formulations a base de nalbuphine et leurs utilisations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB769517A (en) * 1953-10-20 1957-03-06 Merck & Co Inc Analgesic compositions
US3493657A (en) * 1961-03-14 1970-02-03 Mozes Juda Lewenstein Therapeutic compositions of n-allyl-14-hydroxy - dihydronormorphinane and morphine
IL26896A (en) * 1966-01-19 1970-11-30 Endo Lab 14 - Hydroxynormorphinins and 14 - Hydroxynormorphinones
US3773955A (en) * 1970-08-03 1973-11-20 Bristol Myers Co Analgetic compositions
US3879555A (en) * 1970-11-16 1975-04-22 Bristol Myers Co Method of treating drug addicts
GB1390772A (en) * 1971-05-07 1975-04-16 Endo Lab Oral narcotic composition
US3966940A (en) * 1973-11-09 1976-06-29 Bristol-Myers Company Analgetic compositions
US4237140A (en) * 1979-05-18 1980-12-02 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and acetaminophen
US4282215A (en) * 1980-06-17 1981-08-04 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and acetylsalicylic acid, derivative or salt thereof

Also Published As

Publication number Publication date
AR228984A1 (es) 1983-05-13
AU8804282A (en) 1983-03-17
PT75521A (en) 1982-10-01
US4366159A (en) 1982-12-28
PH18772A (en) 1985-09-25
JPS5855422A (ja) 1983-04-01
IL66743A0 (en) 1982-12-31
FI823112L (fi) 1983-03-09
EP0074105A1 (en) 1983-03-16
IL66743A (en) 1986-07-31
AU549070B2 (en) 1986-01-09
HU190699B (en) 1986-10-28
ZA826500B (en) 1984-04-25
GR76702B (OSRAM) 1984-08-29
FI823112A0 (fi) 1982-09-08
NZ201841A (en) 1984-12-14
CA1200501A (en) 1986-02-11

Similar Documents

Publication Publication Date Title
FI823112A7 (fi) Nalbufiini-narkoottinen analgeettikoostumus ja menetelmä kivuntunnon poistamiseksi.
GB2108388B (en) Composition and method for treating alcohol and drug addicts
JPS56161328A (en) Method and composition for reducing pain
FI854497A7 (fi) Desinfiointimenetelmä ja koostumus sitä varten.
DE3587518D1 (de) Vorrichtung zur transdermalen applikation von medikamenten.
JPS54135776A (en) Pharmaceutical composition and method
DK354985D0 (da) Pharmaceutisk komposition til transdermal applikation
FI873044A7 (fi) Farmaseuttinen seosmuoto ja menetelmä senvalmistamiseksi.
DE3273329D1 (en) Analgesic process and composition
FI862500A7 (fi) Menetelmä ja laite tupakan käsittelemiseksi.
FI823292A7 (fi) Sähköunettaja ja menetelmä sen käyttämiseksi.
DE3581357D1 (de) Fernseheinrichtung und verfahren.
FI873905A7 (fi) Terapeuttinen koostumus ja menetelmä.
IT8547565A1 (it) Metodo e dispositivo per idromassaggi
JPS57179117A (en) Analgesic composition and use
DE3373623D1 (en) Pharmaceutical combination composition and associated method
FI861695A7 (fi) Farmaseuttinen valmiste ja menetelmä sen antamiseksi.
EP0197308A3 (en) Composition and method for producing prolonged pain relief
FI851278A7 (fi) Menetelmä ja laite makeisten valmistamiseksi.
FI852973A7 (fi) Analgeettisina aineina käyttökelpoisia 3-karbonyyli-1-aminoalkyyli-1H-indoleja ja niiden valmistus.
IT8522773A0 (it) Composizione farmaceutica contenente fosfocreatina e metodo per preparla.
DE3680594D1 (de) Verbessertes destillationsverfahren und vorrichtung zu seiner durchfuehrung.
FI843500A7 (fi) Eristevalmiste ja menetelmä sen valmistamiseksi.
FI854834A7 (fi) Laite ja menetelmä eläinten hoitamiseksi.
FR2510114B1 (fr) Apovincaminate de phtalidyle, son procede de preparation et son application en therapeutique

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: MAGRUDER, MICHAEL RICHARD